首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1541034

2024-2032 年按細胞激素類型、治療應用、最終用戶和地區分類的細胞激素市場報告

Cytokine Market Report by Cytokine Type, Therapeutic Application, End User, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球細胞激素市場規模達896億美元。

細胞激素是指特定細胞釋放的一組蛋白質、胜肽或糖蛋白，用於控制免疫系統和血球的生長和活性。由於其高親和力皮莫耳濃度，它可以調節免疫、發炎和造血功能。它通常被注射到皮下或肌肉或靜脈中，以幫助預防或控制化療副作用並治療癌症。它還透過發送使異常細胞死亡和正常細胞壽命更長的訊號來增強抗癌活性。目前，它在細胞和基因治療、各種細胞類型的擴增和分化、離體培養和其他治療方法中已被廣泛採用。

細胞激素市場趨勢：

冠狀病毒病 (COVID-19) 透過飛沫傳播，飛沫可誘導促炎細胞因子過量產生，導致急性呼吸窘迫症候群 (ARDS) 加重和組織損傷。由於組織損傷可能導致多重器官衰竭和死亡，因此對細胞因子來管理患者、提高存活率並降低死亡率的解決方案的需求不斷增加。除此之外，癌症盛行率的不斷上升，加上對微創手術（MIS）的需求不斷增加，微創手術可以減少術後疼痛和併發症，並加快恢復時間，從而促進了市場的成長。此外，由於細胞因子可作為健康和疾病的診斷、預後和治療劑以及生物標記物，因此它們在多種功能中越來越受到關注，包括免疫細胞分化、發炎、血管生成、腫瘤發生、神經生物學和病毒發病機轉。除此之外，異位性皮膚炎(AD) 是一種複發性、慢性、發炎性皮膚病，伴隨嚴重搔癢，其病例不斷增加，正在推動AD 發病機制中對新細胞因子的需求，並開發改進的治療標靶。

本報告回答的關鍵問題：

迄今為止，全球細胞激素市場表現如何，未來幾年將如何表現？
COVID-19 對全球細胞激素市場有何影響？
主要區域市場有哪些？
根據細胞激素類型的市場分類是怎樣的？
基於治療應用的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球細胞激素市場的結構如何？
產業競爭程度如何？

A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

Cytokine Market Trends:

The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cytokine type, therapeutic application and end user.

Breakup by Cytokine Type:

Tumor Necrosis Factor-TNF

Interleukins-Il

Interferons-IFN

Epidermal Growth Factor-EGF

Others

Breakup by Therapeutic Application:

Cancer

Asthma and Airway Inflammation

Arthritis

Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Academic and Research Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc. and UCB S.A.

Key Questions Answered in This Report:

How has the global cytokine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cytokine market?
What are the key regional markets?
What is the breakup of the market based on the cytokine type?
What is the breakup of the market based on the therapeutic application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cytokine market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cytokine Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Cytokine Type

6.1 Tumor Necrosis Factor-TNF
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Interleukins-Il
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Interferons-IFN
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Epidermal Growth Factor-EGF
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Application

7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Asthma and Airway Inflammation
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Arthritis
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by End User

8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Contract Research Organizations
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Abcam plc
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Amgen Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Applied Biological Materials Inc. (abm)
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Bio-Techne Corporation
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
- 14.3.6 F. Hoffmann-La Roche AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 GenScript Biotech Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Randox Laboratories Ltd.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Thermo Fisher Scientific Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 UCB S.A.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Cytokine Market: Major Drivers and Challenges
Figure 2: Global: Cytokine Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Cytokine Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Cytokine Market: Breakup by Cytokine Type (in %), 2023
Figure 5: Global: Cytokine Market: Breakup by Therapeutic Application (in %), 2023
Figure 6: Global: Cytokine Market: Breakup by End User (in %), 2023
Figure 7: Global: Cytokine Market: Breakup by Region (in %), 2023
Figure 8: Global: Cytokine (Tumor Necrosis Factor-TNF) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Cytokine (Tumor Necrosis Factor-TNF) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Cytokine (Interleukins-Il) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Cytokine (Interleukins-Il) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Cytokine (Interferons-IFN) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Cytokine (Interferons-IFN) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Cytokine (Epidermal Growth Factor-EGF) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Cytokine (Epidermal Growth Factor-EGF) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Cytokine (Other Cytokine Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Cytokine (Other Cytokine Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Cytokine (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Cytokine (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Cytokine (Asthma and Airway Inflammation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Cytokine (Asthma and Airway Inflammation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Cytokine (Arthritis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Cytokine (Arthritis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Cytokine (Other Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Cytokine (Other Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Cytokine (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Cytokine (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Cytokine (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Cytokine (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Cytokine (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Cytokine Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Cytokine Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Cytokine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Cytokine Industry: SWOT Analysis
Figure 82: Global: Cytokine Industry: Value Chain Analysis
Figure 83: Global: Cytokine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cytokine Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Cytokine Market Forecast: Breakup by Cytokine Type (in Million US$), 2024-2032
Table 3: Global: Cytokine Market Forecast: Breakup by Therapeutic Application (in Million US$), 2024-2032
Table 4: Global: Cytokine Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Cytokine Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Cytokine Market: Competitive Structure
Table 7: Global: Cytokine Market: Key Players

02-2729-4219

+886-2-2729-4219